Zenabis Global Inc trades with the ticker ZENA on the TSX and is in the Drug Manufacturers – Specialty & Generic industry.
Overview
Zenabis Global Inc. engages in the cultivation and sale of medical and adult-use recreational cannabis in Canada and internationally. The company produces and markets strains of dried cannabis under the Zenabis, Namaste, and Re-üp brands; and various oil-based cannabis products. It has 111,200 kg of licensed cannabis cultivation space in three licensed facilities in Canada. The company is headquartered in Vancouver, Canada. As of June 1, 2021, Zenabis Global Inc. operates as a subsidiary of HEXO Corp.
Looking to invest in Zenabis Global Inc? Our analysis brings in the key facts, competitor research and valuation metrics for you to make an informed decision.
Table of Contents
show
ZENA.TO Stock Price and Key Stats
ETF Key Stats
Exchange: TSX
Market Cap : $147.986MM
PE Ratio:
Price: #N/A (Updated: 3/12/2024 0:47:16)
Zenabis Global Inc (ZENA) vs Competitors in Drug Manufacturers – Specialty & Generic
Lets see how ZENA.TO stacks up against others in the Drug Manufacturers – Specialty & Generic asset management industry. We have identified its main peers as:Aleafia Health Inc, Aphria Inc, Acerus Pharmaceuticals Corporation, Correvio Pharma Corp, The Supreme Cannabis Company, Inc
.Drug Manufacturers – Specialty & Generic Industry Comparisons
| Company | Market Cap ($MM) | P/E Ratio | EV/EBITDA | Dividend Yield |
|---|---|---|---|---|
| Aleafia Health Inc (ALEF) | $189.563 | N/A | 0.0 | 0.0% |
| Aphria Inc (APHA) | $4,439.753 | N/A | 598.009 | 0.0% |
| Acerus Pharmaceuticals Corporation (ASP) | $2.775 | N/A | -2.796 | 0.0% |
| Correvio Pharma Corp (CORV) | $37.067 | N/A | 0.0 | 0.0% |
| The Supreme Cannabis Company, Inc (FIRE) | $255.583 | N/A | 0.0 | 0.0% |
EV/EBITDA: Enterprise Value to Earnings Before Interest, Taxes, Depreciation, and Amortization – this ratio compares the value of a company, including debt, to the company’s cash earnings less non-cash expenses
Industry: companies that have a lot in common
Market Cap: Market Capitalization – the total value of all a corporation’s stock
N/A: Not Applicable or Not Available
P/E: Price-to-Earnings – this ratio relates a corporation’s share price to its earnings per share
Price: Stock Price – current value to buyers and sellers
Dividend Yield: Dividend or Distribution Yield
Comparisons within Drug Manufacturers – Specialty & Generic
- Zenabis Global Inc (ZENA) vs Aleafia Health Inc (ALEF)
- ALEF has higher EPS (-0.274 vs -0.39). ALEF provides dividends, while ZENA does not. ALEF and ZENA both have P/E’s under 0.
- Zenabis Global Inc (ZENA) vs Aphria Inc (APHA)
- APHA has higher EPS (0.116 vs -0.39). APHA provides dividends, while ZENA does not. APHA and ZENA both have P/E’s under 0.
- Zenabis Global Inc (ZENA) vs Acerus Pharmaceuticals Corporation (ASP)
- ZENA has higher EPS (-0.39 vs -4.41). ASP provides dividends, while ZENA does not. ASP and ZENA both have P/E’s under 0.
- Zenabis Global Inc (ZENA) vs Correvio Pharma Corp (CORV)
- ZENA has higher EPS (-0.39 vs -0.879). CORV provides dividends, while ZENA does not. CORV and ZENA both have P/E’s under 0.
- Zenabis Global Inc (ZENA) vs The Supreme Cannabis Company, Inc (FIRE)
- FIRE has higher EPS (-0.052 vs -0.39). FIRE provides dividends, while ZENA does not. FIRE and ZENA both have P/E’s under 0.
Our Recommendation: Review
May not stand out on key metrics or lacks sufficient data for a strong recommendation.
How to Buy ZENA stock on the TSX
You can buy on pretty much any online brokerage in Canada, since it trades on the TSX. If you are looking for some easy options take a look at these two:| Image | Product Title | Features | Price |
|---|---|---|---|
Editor's Choice  |
| Get $25 Signup Bonus | |
Reliable Pick  |
| Get $50 Free Stock Trades |
